Jean Marie Elwing MD

Pulmonology•Cincinnati, OH

Critical Care Medicine, Pleural Disease, Pulmonary Vascular Medicine

Professor, Director Pulmonary Hypertension Program, Pulmonary and Critical Care Medicine, University of Cincinnati College of Medicine

Join to View Full Profile

Holmes Hospital, 200 Albert Sabin Way3rd Floor PulmonaryCincinnati, OH 45227
Phone+1 513-475-8523
Fax+1 513-475-7327

Summary

Dr. Jean Elwing, based in Cincinnati, Ohio, is a physician specializing in Pulmonology with sub-specialties in Pulmonary Vascular Medicine. She completed her education and residency at Saint Louis University School of Medicine and further pursued a fellowship in Pulmonary Disease and Critical Care Medicine from the University of Cincinnati Medical Center/College of Medicine. Dr. Elwing has experience in the management of conditions such as pulmonary hypertension, pulmonary embolism and chronic right heart failure. She has been involved in multiple clinical trials related to her specialty and has published in several respected journals in her field.

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
St Louis University School of MedicineResidency, Internal Medicine/Pediatrics, 1997 - 2001
Saint Louis University School of MedicineClass of 1997

Certifications & Licensure

OH State Medical License 2003 - 2027
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Eisenmenger Quality Enhancement Research Initiative Start of enrollment: 2012 Jul 01
COMPLETED
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31
Completed
Phase 2
Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH Start of enrollment: 2018 Jul 15
Terminated
Phase 2
Pulmonary Hypertension Association Registry Start of enrollment: 2015 Oct 01
Recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Heart Rate Variability as a Marker of Disease Severity in Pulmonary Arterial Hypertension: A Prospective Cohort Study.
Arun Jose, Alex D Moseley, Manisha Das, Robert E O'Donnell, Jean M Elwing
Pulmonary Circulation. 2025-04-01
Dual prostacyclin infusions: A case report of a patient symptom-driven transition from high-dose intravenous epoprostenol to subcutaneous treprostinil for the treatmen...
Jessica N Stone, Dalton J Kuebel, Maria R Guido, Jean M Elwing, Arun Jose
American Journal of Health-System Pharmacy. 2025-02-20
Association of Cardiopulmonary Hemodynamics and Outcomes in Pulmonary Hypertension Following Kidney Transplantation: A Multicenter Retrospective Cohort Study.
Arun Jose, Sathish S Kumar, Leonid Gorelik, Samuel H Friedman, Antolin S Flores
Chest. 2024-12-01

Press Mentions

PHA Recognizes Outstanding Members of the Pulmonary Hypertension CommunitySeptember 3rd, 2024
Advances Made in UC Research Extending LivesOctober 17th, 2022
Team PHenomenal Hope Sets Out PH Awareness Month ChallengesNovember 2nd, 2020
Join now to see all

Professional Memberships

American College of Physicians - ACP
Member